Tomoko Horinouchi
- Immunology and Allergy top 2%
- Cell Adhesion Molecules Research 22
- Nephrology top 2%
- Renal Diseases and Glomerulopathies 25
- Hematology top 10%
- Platelet Disorders and Treatments 7
- Genetics top 10%
- Genetic and Kidney Cyst Diseases 7
- Genetic Syndromes and Imprinting 6
-
- Renal and related cancers 26
- Ion Transport and Channel Regulation 9
- RNA Research and Splicing 8
- Co-authors
- Kandai NozuKazumoto IijimaTomohiko YamamuraChina NaganoKoichi NakanishiNana SakakibaraHiroshi KaitoShogo Minamikawa
- Journals
- SHILAP Revista de lepidopterología (1 paper)Scientific Reports (4 papers)Kidney International (1 paper)
- Partner nations
- JapanIndonesiaUnited Kingdom
In The Last Decade
Tomoko Horinouchi
71 papers receiving 794 citations
Peers
Comparison fields: 5 of 68
- Immunology and Allergy 236
- Nephrology 217
- Hematology 90
- Genetics 207
- Molecular Biology 472
Countries citing papers authored by Tomoko Horinouchi
This map shows the geographic impact of Tomoko Horinouchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoko Horinouchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoko Horinouchi more than expected).
Fields of papers citing papers by Tomoko Horinouchi
This network shows the impact of papers produced by Tomoko Horinouchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoko Horinouchi. The network helps show where Tomoko Horinouchi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tomoko Horinouchi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 2 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 13 | |
| 12 | 2022 | 2 | |
| 13 | 2021 | 7 | |
| 14 | 2021 | 19 | |
| 15 | 2020 | 63 | |
| 16 | 2019 | 2 | |
| 17 | 2018 | 127 | |
| 18 | 2018 | 9 | |
| 19 | 2018 | 10 | |
| 20 | 2017 | 7 |
About Tomoko Horinouchi
Tomoko Horinouchi is a scholar working on Nephrology, Immunology and Allergy and Hematology, having authored 83 papers that have together received 804 indexed citations. Recurring topics across this work include Renal and related cancers (26 papers), Renal Diseases and Glomerulopathies (25 papers), Cell Adhesion Molecules Research (22 papers), Ion Transport and Channel Regulation (9 papers), RNA Research and Splicing (8 papers), Platelet Disorders and Treatments (7 papers), Genetic and Kidney Cyst Diseases (7 papers) and Genetic Syndromes and Imprinting (6 papers). The work is most often cited by research in Immunology and Allergy (236 citations), Nephrology (217 citations) and Hematology (90 citations). Tomoko Horinouchi has collaborated with scholars based in Japan, Indonesia and United Kingdom. Frequent co-authors include Kandai Nozu, Kazumoto Iijima, Tomohiko Yamamura, China Nagano, Koichi Nakanishi, Nana Sakakibara, Hiroshi Kaito, Shogo Minamikawa, Yuya Aoto and Hiroaki Nagase. Their work appears in journals such as SHILAP Revista de lepidopterología, Scientific Reports and Kidney International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.